Hasenin Al-Khersan1, Kaanan P Shah2, Segun C Jung3, Alex Rodriguez3, Ravi K Madduri3, Michael A Grassi4,5. 1. Pritzker School of Medicine, The University of Chicago, Chicago, IL, 60637, USA. 2. Section of Genetic Medicine, The University of Chicago, Chicago, IL, 60637, USA. 3. Argonne National Laboratory - Computation Institute, The University of Chicago, Chicago, IL, 60637, USA. 4. Grassi Retina, Naperville, IL, 60564, USA. mag@grassiretina.com. 5. Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, 1012 95th St., Suite 9, Naperville, IL, 60564, USA. mag@grassiretina.com.
Abstract
PURPOSE: Retinitis pigmentosa (RP) is a genetically heterogeneous inherited retinal dystrophy. To date, over 80 genes have been implicated in RP. However, the disease demonstrates significant locus and allelic heterogeneity not entirely captured by current testing platforms. The purpose of the present study was to characterize the underlying mutation in a patient with RP without a molecular diagnosis after initial genetic testing. METHODS: Whole-exome sequencing of the affected proband was performed. Candidate gene mutations were selected based on adherence to expected genetic inheritance pattern and predicted pathogenicity. Sanger sequencing of MERTK was completed on the patient's unaffected mother, affected brother, and unaffected sister to determine genetic phase. RESULTS: Eight sequence variants were identified in the proband in known RP-associated genes. Sequence analysis revealed that the proband was a compound heterozygote with two independent mutations in MERTK, a novel nonsense mutation (c.2179C > T) and a previously reported missense variant (c.2530C > T). The proband's affected brother also had both mutations. Predicted phase was confirmed in unaffected family members. CONCLUSION: Our study identifies a novel nonsense mutation in MERTK in a family with RP and no prior molecular diagnosis. The present study also demonstrates the clinical value of exome sequencing in determining the genetic basis of Mendelian diseases when standard genetic testing is unsuccessful.
PURPOSE:Retinitis pigmentosa (RP) is a genetically heterogeneous inherited retinal dystrophy. To date, over 80 genes have been implicated in RP. However, the disease demonstrates significant locus and allelic heterogeneity not entirely captured by current testing platforms. The purpose of the present study was to characterize the underlying mutation in a patient with RP without a molecular diagnosis after initial genetic testing. METHODS: Whole-exome sequencing of the affected proband was performed. Candidate gene mutations were selected based on adherence to expected genetic inheritance pattern and predicted pathogenicity. Sanger sequencing of MERTK was completed on the patient's unaffected mother, affected brother, and unaffected sister to determine genetic phase. RESULTS: Eight sequence variants were identified in the proband in known RP-associated genes. Sequence analysis revealed that the proband was a compound heterozygote with two independent mutations in MERTK, a novel nonsense mutation (c.2179C > T) and a previously reported missense variant (c.2530C > T). The proband's affected brother also had both mutations. Predicted phase was confirmed in unaffected family members. CONCLUSION: Our study identifies a novel nonsense mutation in MERTK in a family with RP and no prior molecular diagnosis. The present study also demonstrates the clinical value of exome sequencing in determining the genetic basis of Mendelian diseases when standard genetic testing is unsuccessful.
Authors: Paolo Carnevali; Jonathan Baccash; Aaron L Halpern; Igor Nazarenko; Geoffrey B Nilsen; Krishna P Pant; Jessica C Ebert; Anushka Brownley; Matt Morenzoni; Vitali Karpinchyk; Bruce Martin; Dennis G Ballinger; Radoje Drmanac Journal: J Comput Biol Date: 2011-12-16 Impact factor: 1.479
Authors: P M D'Cruz; D Yasumura; J Weir; M T Matthes; H Abderrahim; M M LaVail; D Vollrath Journal: Hum Mol Genet Date: 2000-03-01 Impact factor: 6.150
Authors: Christina L McHenry; Yuhui Liu; Wei Feng; Anita R Nair; Kecia L Feathers; Xiaoling Ding; Andreas Gal; Douglas Vollrath; Paul A Sieving; Debra A Thompson Journal: Invest Ophthalmol Vis Sci Date: 2004-05 Impact factor: 4.799
Authors: Fahad A Al-Muhanna; Abdullah M Al-Rubaish; Chittibabu Vatte; Shamim Shaikh Mohiuddin; Cyril Cyrus; Arafat Ahmad; Mohammed Shakil Akhtar; Mohammad Ahmad Albezra; Rudaynah A Alali; Afnan F Almuhanna; Kai Huang; Lusheng Wang; Feras Al-Kuwaiti; Tamer S Ahmed Elsalamouni; Abdullah Al Hwiesh; Xiaoyan Huang; Brendan Keating; Jiankang Li; Matthew B Lanktree; Amein K Al-Ali Journal: Ren Fail Date: 2019-11 Impact factor: 2.606